Publications

1 2 3 4 5 6 10 18 27 35

J. Fucikova, J.P. Kline, L. Galluzzi, R. Spisek.

Calreticulin arms NK cells against leukemia.

Oncoimmunology. 2019 Oct 9;9(1):1671763. doi: 10.1080/2162402X.2019.1671763. eCollection 2020.

I. Truxova, L. Kasikova, C. Salek, M. Hensler, D. Lysak, P. Holicek, P. Bilkova, M. Holubova, X. Chen, R. Mikyskova, M. Reinis, M. Kovar, B. Tomalova, J.P. Kline, L. Galluzzi, R. Spisek, J. Fucikova

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.

Haematologica. 2019 Oct 3. pii: haematol.2019.223933. doi: 10.3324/haematol.2019.223933. [Epub ahead of print]

L. Kasikova, I. Truxova, I. Cremer, C. Sautes-Fridman, O. Kepp, G. Kroemer, R. Spisek, J. Fucikova.

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death.

Methods Enzymol. 2020;632:15-25. doi: 10.1016/bs.mie.2019.05.025. Epub 2019 Jul 8.